Expression of cyclin A, cyclin e and p27 in normal, hyperplastic and frankly malignant endometrial samples

Journal of Obstetrics and Gynaecology

Volumn 33, Issue 5, 2013, Pages 508-511

  Gezginc, S T ^a   Celik, C ^b   Dogan, N U ^b   Toy, H ^a   Tazegul, A ^b   Colakoglu, M C ^a  

^a NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Cyclin A; Cyclin E; Endometrial cancer; Endometrial hyperplasia; P27; Proliferative endometrium

Indexed keywords

CYCLIN A; CYCLIN E; PROTEIN P27;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; CARCINOMA; CASE-CONTROL STUDIES; CYCLIN A; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED;

EID: 84879833705     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2013.776024     Document Type: Article

References (22)

1. Aaltomaa S, Eskelinen M, Lipponen P. 1999. Expression of cyclin A and D proteins in prostate cancer and their relation to clinicopathological variables and patient survival. Prostate 38: 175-182. (Pubitemid 29054933)
2. Bergeron C , Nogales FF , Masseroli M , Abeler V , Duvillard P , Muller-Holzner E et al. 1999. A multicentric European study testing the reproducibility of the WHO classifi cation of endometrial hyperplasia with a proposal of a simplifi ed working classifi cation for biopsy and curettage specimens. American Journal of Surgical Pathology 23: 1102-1108. (Pubitemid 29409773)
3. Chao Y , Shih YL, Chiu JH, Chau GY , Lui WY , Yang WK et al. 1998. Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Research 58: 985-990. (Pubitemid 28182468)
4. Craig C, Wersto R , Kim M, Ohri E, Li Z, Katayose D et al. 1997. A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene 14 : 2283-2289. (Pubitemid 27260720)
5. Dobashi Y , Shoji M, Jiang SX, Kobayashi M, Kawakubo Y , Kameya T. 1998. Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas. American Journal of Pathology 153 : 963-972. (Pubitemid 28419049)
6. Donnellan R , Kleinschmidt I, Chetty R. 2001. Cyclin E immunoexpression in breast ductal carcinoma: pathologic correlations and prognostic implications. Human Pathology 32: 89-94. (Pubitemid 32150633)
7. Grana X, Reddy EP. 1995. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11: 211-219.
8. Hubalek MM, Widschwendter A, Erdel M, Gschwendtner A, Fiegl HM, Muller HM et al. 2004. Cyclin E dysregulation and chromosomal instability in endometrial cancer. Oncogene 23: 4187-4192. (Pubitemid 38747952)
9. Kashima H , Shiozawa T , Miyamoto T , Suzuki A , Uchikawa J , Kurai M et al. 2009. Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E. Endocrine-related Cancer 16: 113-122.
10. Kyushima N , Watanabe J , Hata H , Jobo T , Kameya T , Kuramoto H. 2002. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables. Journal of Cancer Research and Clinical Oncology 128: 307-312. (Pubitemid 34569351)
11. Lindahl T , Landberg G , Ahlgren J , Nordgren H , Norberg T , Klaar S et al. 2004. Overexpression of cyclin E protein is associated with specifi c mutation types in the p53 gene and poor survival in human breast cancer. Carcinogenesis 25: 375-380. (Pubitemid 38344404)
12. Masciullo V , Susini T , Zamparelli A, Bovicelli A, Minimo C, Massi D et al. 2003. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas. Clinical Cancer Research 9: 5332-5338. (Pubitemid 37413588)
13. Nielsen NH, Emdin SO , Cajander J , Landberg G. 1997. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene 14 : 295-304. (Pubitemid 27073084)
14. Paterlini P , Suberville AM, Zindy F , Melle J , Sonnier M, Marie JP et al. 1993. Cyclin A expression in human hematological malignancies: a new marker of cell proliferation. Cancer Research 53: 235-238. (Pubitemid 23031829)
15. Sherr CJ. 1995. D-type cyclins. Trends in Biochemical Sciences 20: 187-190.
16. Sherr CJ , Roberts JM. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes and Development 13: 1501-1512. (Pubitemid 29297917)
17. Shih HC , Shiozawa T , Kato K, Imai T , Miyamoto T , Uchikawa J et al. 2003. Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator. Human Pathology 34: 471-478. (Pubitemid 36666813)
18. Shin I, Yakes FM, Rojo F , Shin NY , Bakin AV , Baselga J et al. 2002. PKB/ Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nature Medicine 8: 1145-1152. (Pubitemid 35175970)
19. Spruck CH, Won KA , Reed SI. 1999. Deregulated cyclin E induces chromosome instability. Nature 401: 297-300.
20. Wang A, Yoshimi N, Suzui M, Yamauchi A, Tarao M, Mori H. 1996. Diff erent expression patterns of cyclins A, D1 and E in human colorectal cancer. Journal of Cancer Research and Clinical Oncology 122: 122-126. (Pubitemid 26037056)
21. Watanabe J , Sato H, Kanai T , Kamata Y , Jobo T , Hata H et al. 2002. Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus-correlation with proliferation and clinicopathological parameters. British Journal of Cancer 87: 81-85.
22. Zaino RJ. 2009. FIGO staging of endometrial adenocarcinoma: a critical review and proposal. International Journal of Gynecological Pathology 28 : 1-9.